Titan Pharmaceuticals
TTNP
TTNP
24 hedge funds and large institutions have $374K invested in Titan Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 4 closing their positions.
Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
1
Closed
4
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$7K
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$135K |
| 2 |
VF
2
Virtu Financial
New York
|
$35K |
| 3 |
3
Millennium Management
New York
|
$35K |
| 4 |
HF
4
HRT Financial
New York
|
$29K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$15K |
Top Sellers
| 1 |
AC
1
Armistice Capital
New York
|
$0 |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$42K |
| 3 |
3
Barclays
London,
United Kingdom
|
$0 |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Osaic Holdings
Scottsdale,
Arizona
| $0 | 14 | – | – |
|
27
Fidelity Investments
Boston,
Massachusetts
| $0 | 1 | – | – |
|
28
Bank of America
Charlotte,
North Carolina
| $0 | 206 | – | – |
|
29
Wells Fargo
San Francisco,
California
| $0 | 81 | +13 | +19% |
|
30
Simplex Trading
Chicago,
Illinois
| $0 | 483 | +129 | +36% |
|